Underlying mechanisms of nephroprotective effects with SGLT2i in CKD

10' education - June 14, 2019 - ERA-EDTA 2019 - Paola Fioretto, MD – Padua, Italy - Online CME

Paola Fioretto discusses possible underlying mechanisms of the nephroprotective effects of SGLT2i, as observed in large clinical trials.

Video navigation menu

Possible mechanisms responsible for CV and renal protection with SGLT2i 0:46
Effects of SGLT2i on renal hemodynamics 2:24
Potential pathways of renal protective effects with SGLT2i 7:53

Educational information

This lecture by Paola Fioretto was part of a CME-accredited symposium "SGLT2 Inhibition in CKD: Discussing the key questions and evidence" held during ERA EDTA 2019 in Budapest, Hungary.

Faculty

Paola Fioretto, MD, Associate Professor in Medicine at the University of Padova, Italy

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim / Lilly

View slides of the presentation View the meeting report of this symposium

Online-CME

This is available as accredited online CME on coursepath for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.